video corpo

DNA sequencing reagent kit AmpliSeq™ 20019160
NGSfor mutation detectionfor cancers

DNA sequencing reagent kit
DNA sequencing reagent kit
Add to favorites
Compare this product


for DNA sequencing, NGS, for mutation detection, for cancers, FFPE tissues, blood sample
Tested parameter
for genes


Product Highlights The AmpliSeq for Illumina Comprehensive Cancer Panel provides a targeted resequencing solution for analyzing somatic mutations across 409 genes with known associations to cancer. Key features include: Relevant Gene Content Target all-exon coverage of 409 cancer-associated genes Fast, Streamlined Workflow Prepare sequencing-ready libraries in a single day from as little as 1 ng of high quality or 10 ng of formalin-fixed, paraffin-embedded (FFPE) input samples Accurate Data Detect somatic mutations below 5% frequency using local or cloud analysis The Comprehensive Cancer Panel is part of an integrated workflow that includes AmpliSeq for Illumina polymerase chain reaction (PCR)-based library preparation, Illumina sequencing by synthesis (SBS) next-generation sequencing (NGS) technology, and automated analysis. This panel detects variants within multiple cancer types, including lung, colon, breast, ovarian, melanoma, and prostate malignancies. The ready-to-use panel saves you the time and effort of identifying targets, designing primers, and optimizing panels.


No catalogs are available for this product.

See all of Illumina, Inc.‘s catalogs
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.